Alendronic Acid

Back to search

Molecule Structure

Scientific Name

Alendronic Acid

Description of the Drug

Alendronic acid is a bisphosphonate drug that prevents osteoclastic bone resorption which is used for the prevention and treatment of osteoporosis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00630

Brand Name(s)

Binosto, Fosamax

Company Owner(s)

Cipla Ltd, Organon Llc, Watson Laboratories Inc, Picket Pharmaceuticals Inc, Merck And Co Inc, Mylan Pharmaceuticals Inc, Impax Laboratories Inc, Ascend Therapeutics Us Llc, Hangzhou Minsheng Binjiang Pharmaceutical Co Ltd, Aurobindo Pharma Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Farnesyl diphosphate synthase SINGLE PROTEIN INHIBITOR CHEMBL1782

Unichem Links

Atlas alendronate
SureChEMBL SCHEMBL18898
PharmGKB PA448082
Human Metabolome Database HMDB0001915
DrugBank DB00630
PubChem: Thomson Pharma 15196679
PubChem 2088 44400013
Mcule MCULE-3180289877
LINCS LSM-5831
Nikkaji J363.022F
PDBe 212
BindingDB 25313
EPA CompTox Dashboard DTXSID5022568
DrugCentral 112
Brenda 212814 5337
ChemicalBook CB3380835
Guide to Pharmacology 3141
rxnorm ALENDRONIC ACID ALENDRONATE SODIUM FOSAMAX ALENDRONATE BINOSTO
KEGG Ligand C07752
ChEBI 2567
ZINC ZINC000003801919